Published: 2017-05-27

Intrathecal baclofen in management of a patient with very severe tetanus

Madhusudan R. Jaju, M. Goverdhan, Pavan Kumar Reddy N., Sirisha Rao Muttavarapu, V. Chandra Sekhar, Siddharth Bandla, Srikanth Rammohan, Shashank Kumar Srivastav


Tetanus is uncommon in developed countries. The majority of tetanus cases occur in third world countries and 50% of these cases occur in neonates. There are more than 800,000 deaths due to tetanus each year in the world. We present a case of 40-year-old male patient diagnosed to have very severe tetanus - Grade IV as per Ablett classification of severity, managed in our hospital with aggressive treatment for 27-days and use of intrathecal baclofen he showed drastic improvement in this status.  He was discharged in neurological intact conditions with hemodynamic stability.



Autonomic instability, Intrathecal baclofen, Very severe tetanus

Full Text:



Schwartz E, Rodeisperger E. Skin and soft tissue infections. In: Schillinger D, Harwood-Nuss A. Infections in emergency medicine. Vol. 2. New York; Churchill Livingstone, 1990;63-113.

Farrar JJ, Yen LM, Cook T (2000). Neurological aspects of tropical disease J Neurol Neurosurg Psychiatr. 2000;69:292-301.

Bleck TP, Brauner JS. Tetanus. In: Scheld WM, Whitely RJ, Durack DT, eds. Infections of the central nervous system. 2nd ed. Philadelphia; Lippincott-Raven; 1997:629-53.

Samuel S, Groleau G. Tetanus in the emergency department: A current review. J Emerg Medline. 2001;20:357-65.

Blake PA, Feldman RA, Buchanan TM. Serologic therapy of tetanus in the United States, 1965-1971. JAMA. 1976;235:42-4.

Ahmadsyah I, Salim A. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. Br J Med. 1985;291:648-50.

Ataro P, Mushatt D, Ahsan S. Tetanus: a review. South Med J. 2011;104:613-7.